Literaturverzeichnis

[1] Bjorklund, L. M.; Sanchez-Pernaute, R.; Chung, S.; Andersson, T.; Chen, I. Y.; McNaught, K. S.; Brownell, A. L.; Jenkins, B. G.; Wahlestedt, C.; Kim, K. S. und Isacson, O. (2002): Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model, Proc.Natl.Acad.Sci.U.S.A (Band 99), Nr. 4, Seite 2344-2349. URL: PM:11782534

[2] Isacson, O.; Bjorklund, L. M. und Schumacher, J. M. (2003): Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells, Ann.Neurol. (Band 53 Suppl 3), Seite S135-S146. URL: PM:12666105

[3] Sun, Z. H.; Lai, Y. L.; Zeng, W. W.; Zhao, D.; Ye, Z. W.; Zuo, H. C. und Xie, Z. P. (2003): Mesencephalic progenitors can improve rotational behavior and reconstruct nigrostriatal pathway in PD rats, Acta Neurochir.Suppl (Band 87), Seite 175-180. URL: PM:14518548

[4] Fukunaga, A.; Uchida, K.; Hara, K.; Kuroshima, Y. und Kawase, T. (1999): Differentiation and angiogenesis of central nervous system stem cells implanted with mesenchyme into ischemic rat brain, Cell Transplant. (Band 8), Nr. 4, Seite 435-441. URL: PM:10478726

[5] Fukunaga, A.; Kawase, T. und Uchida, K. (2003): Functional recovery after simultaneous transplantation with neuro-epithelial stem cells and adjacent mesenchymal tissues into infarcted rat brain, Acta Neurochir.(Wien.) (Band 145), Nr. 6, Seite 473-80, discussion. URL: PM:12836072

[6] Kelly, S.; Bliss, T. M.; Shah, A. K.; Sun, G. H.; Ma, M.; Foo, W. C.; Masel, J.; Yenari, M. A.; Weissman, I. L.; Uchida, N.; Palmer, T. und Steinberg, G. K. (2004): Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex, Proc.Natl.Acad.Sci.U.S.A (Band 101), Nr. 32, Seite 11839-11844. URL: PM:15280535

[7] Ben Hur, T.; Einstein, O.; Mizrachi-Kol, R.; Ben Menachem, O.; Reinhartz, E.; Karussis, D. und Abramsky, O. (2003): Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis, Glia (Band 41), Nr. 1, Seite 73-80. URL: PM:12465047

[8] Bulte, J. W.; Ben Hur, T.; Miller, B. R.; Mizrachi-Kol, R.; Einstein, O.; Reinhartz, E.; Zywicke, H. A.; Douglas, T. und Frank, J. A. (2003): MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain, Magn Reson.Med. (Band 50), Nr. 1, Seite 201-205. URL: PM:12815696

[9] Pluchino, S.; Quattrini, A.; Brambilla, E.; Gritti, A.; Salani, G.; Dina, G.; Galli, R.; Del Carro, U.; Amadio, S.; Bergami, A.; Furlan, R.; Comi, G.; Vescovi, A. L. und Martino, G. (2003): Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis, Nature (Band 422), Nr. 6933, Seite 688-694. URL: PM:12700753

[10] Check, E. (2003): Parkinson's transplant therapy faces setback, Nature (Band 424), Nr. 6952, Seite 987. URL: PM:12944933

[11] Eskandar, E. N.; Flaherty, A.; Cosgrove, G. R.; Shinobu, L. A. und Barker, F. G. (2003): Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample, J.Neurosurg. (Band 99), Nr. 5, Seite 863-871. URL: PM:14609166

[12] Lindvall, O.; Sawle, G.; Widner, H.; Rothwell, J. C.; Bjorklund, A.; Brooks, D.; Brundin, P.; Frackowiak, R.; Marsden, C. D.; Odin, P. und . (1994): Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease, Ann.Neurol. (Band 35), Nr. 2, Seite 172-180. URL: PM:8109898

[13] Arbab, A. S.; Bashaw, L. A.; Miller, B. R.; Jordan, E. K.; Bulte, J. W. und Frank, J. A. (2003): Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques, Transplantation (Band 76), Nr. 7, Seite 1123-1130. URL: PM:14557764

[14] Bowen, C. V.; Zhang, X.; Saab, G.; Gareau, P. J. und Rutt, B. K. (2002): Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells, Magn Reson.Med. (Band 48), Nr. 1, Seite 52-61. URL: PM:12111931

[15] Hinds, K. A.; Hill, J. M.; Shapiro, E. M.; Laukkanen, M. O.; Silva, A. C.; Combs, C. A.; Varney, T. R.; Balaban, R. S.; Koretsky, A. P. und Dunbar, C. E. (2003): Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells, Blood (Band 102), Nr. 3, Seite 867-872. URL: PM:12676779

[16] Renshaw, P. F.; Owen, C. S.; McLaughlin, A. C.; Frey, T. G. und Leigh, J. S., Jr. (1986): Ferromagnetic contrast agents: a new approach, Magn Reson.Med. (Band 3), Nr. 2, Seite 217-225. URL: PM:3713487

[17] Brooks, R. A.; Moiny, F. und Gillis, P. (2001): On T2-shortening by weakly magnetized particles: the chemical exchange model, Magn Reson.Med. (Band 45), Nr. 6, Seite 1014-1020. URL: PM:11378879

[18] Gillis, P.; Moiny, F. und Brooks, R. A. (2002): On T(2)-shortening by strongly magnetized spheres: a partial refocusing model, Magn Reson.Med. (Band 47), Nr. 2, Seite 257-263. URL: PM:11810668

[19] Taupitz, M.; Schmitz, S. und Hamm, B. (2003): [Superparamagnetic iron oxide particles: current state and future development], Rofo (Band 175), Nr. 6, Seite 752-765. URL: PM:12811686

[20] Moore, A.; Weissleder, R. und Bogdanov, A., Jr. (1997): Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages, J.Magn Reson.Imaging (Band 7), Nr. 6, Seite 1140-1145. URL: PM:9400860

[21] Taupitz, M.; Schnorr, J.; Abramjuk, C.; Wagner, S.; Pilgrimm, H.; Hunigen, H. und Hamm, B. (2000): New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits, J.Magn Reson.Imaging (Band 12), Nr. 6, Seite 905-911. URL: PM:11105029

[22] de Laquintane, B. D.; Dousset, V.; Solanilla, A.; Petry, K. G. und Ripoche, J. (2002): Iron particle labeling of haematopoietic progenitor cells: an in vitro study, Biosci.Rep. (Band 22), Nr. 5-6, Seite 549-554. URL: PM:12635852

[23] Bulte, J. W.; Zhang, S.; van Gelderen, P.; Herynek, V.; Jordan, E. K.; Duncan, I. D. und Frank, J. A. (1999): Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination, Proc.Natl.Acad.Sci.U.S.A (Band 96), Nr. 26, Seite 15256-15261. URL: PM:10611372

[24] Fleige, G.; Nolte, C.; Synowitz, M.; Seeberger, F.; Kettenmann, H. und Zimmer, C. (2001): Magnetic labeling of activated microglia in experimental gliomas, Neoplasia. (Band 3), Nr. 6, Seite 489-499. URL: PM:11774031

[25] Hoehn, M.; Kustermann, E.; Blunk, J.; Wiedermann, D.; Trapp, T.; Wecker, S.; Focking, M.; Arnold, H.; Hescheler, J.; Fleischmann, B. K.; Schwindt, W. und Buhrle, C. (2002): Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat, Proc.Natl.Acad.Sci.U.S.A (Band 99), Nr. 25, Seite 16267-16272. URL: PM:12444255

[26] Weissleder, R.; Moore, A.; Mahmood, U.; Bhorade, R.; Benveniste, H.; Chiocca, E. A. und Basilion, J. P. (2000): In vivo magnetic resonance imaging of transgene expression, Nat Med (Band 6), Nr. 3, Seite 351-355. URL: PM:10700241

[27] Jendelova, P.; Herynek, V.; DeCroos, J.; Glogarova, K.; Andersson, B.; Hajek, M. und Sykova, E. (2003): Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles, Magn Reson.Med. (Band 50), Nr. 4, Seite 767-776. URL: PM:14523963

[28] Zhang, Z. G.; Jiang, Q.; Zhang, R.; Zhang, L.; Wang, L.; Zhang, L.; Arniego, P.; Ho, K. L. und Chopp, M. (2003): Magnetic resonance imaging and neurosphere therapy of stroke in rat, Ann.Neurol. (Band 53), Nr. 2, Seite 259-263. URL: PM:12557295

[29] von, Campenhausen S.; Bornschein, B.; Wick, R.; Botzel, K.; Sampaio, C.; Poewe, W.; Oertel, W.; Siebert, U.; Berger, K. und Dodel, R. (2005): Prevalence and incidence of Parkinson's disease in Europe, Eur.Neuropsychopharmacol. (Band 15), Nr. 4, Seite 473-490. URL: PM:15963700

[30] Lindvall, O. und Hagell, P. (2001): Cell therapy and transplantation in Parkinson's disease, Clin.Chem.Lab Med. (Band 39), Nr. 4, Seite 356-361. URL: PM:11388662

[31] Levy, Y. S.; Stroomza, M.; Melamed, E. und Offen, D. (2004): Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease, J.Mol.Neurosci. (Band 24), Nr. 3, Seite 353-386. URL: PM:15655260

[32] Carvey, P. M.; Ling, Z. D.; Sortwell, C. E.; Pitzer, M. R.; McGuire, S. O.; Storch, A. und Collier, T. J. (2001): A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease, Exp.Neurol. (Band 171), Nr. 1, Seite 98-108. URL: PM:11520124

[33] Riaz, S. S.; Jauniaux, E.; Stern, G. M. und Bradford, H. F. (2002): The controlled conversion of human neural progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro, Brain Res.Dev.Brain Res. (Band 136), Nr. 1, Seite 27-34. URL: PM:12036514

[34] Gerlach, M.; Braak, H.; Hartmann, A.; Jost, W. H.; Odin, P.; Priller, J. und Schwarz, J. (2002): Current state of stem cell research for the treatment of Parkinson's disease, J.Neurol. (Band 249 Suppl 3), Seite III/33-III/35. URL: PM:12522570

[35] Lee, S. H.; Lumelsky, N.; Studer, L.; Auerbach, J. M. und McKay, R. D. (2000): Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells, Nat.Biotechnol. (Band 18), Nr. 6, Seite 675-679. URL: PM:10835609

[36] Correia, A. S.; Anisimov, S. V.; Li, J. Y. und Brundin, P. (2005): Stem cell-based therapy for Parkinson's disease, Ann.Med. (Band 37), Nr. 7, Seite 487-498. URL: PM:16278162

[37] Fujikawa, T.; Oh, S. H.; Pi, L.; Hatch, H. M.; Shupe, T. und Petersen, B. E. (2005): Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells, Am.J.Pathol. (Band 166), Nr. 6, Seite 1781-1791. URL: PM:15920163

[38] Erdo, F.; Buhrle, C.; Blunk, J.; Hoehn, M.; Xia, Y.; Fleischmann, B.; Focking, M.; Kustermann, E.; Kolossov, E.; Hescheler, J.; Hossmann, K. A. und Trapp, T. (2003): Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke, J.Cereb.Blood Flow Metab (Band 23), Nr. 7, Seite 780-785. URL: PM:12843782

[39] Sanchez-Pernaute, R.; Studer, L.; Ferrari, D.; Perrier, A.; Lee, H.; Vinuela, A. und Isacson, O. (2005): Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation, Stem Cells (Band 23), Nr. 7, Seite 914-922. URL: PM:15941857

[40] Lu, D.; Li, Y.; Wang, L.; Chen, J.; Mahmood, A. und Chopp, M. (2001): Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury, J.Neurotrauma (Band 18), Nr. 8, Seite 813-819. URL: PM:11526987

[41] Lu, D.; Mahmood, A.; Wang, L.; Li, Y.; Lu, M. und Chopp, M. (2001): Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome, Neuroreport (Band 12), Nr. 3, Seite 559-563. URL: PM:11234763

[42] Munoz, J. R.; Stoutenger, B. R.; Robinson, A. P.; Spees, J. L. und Prockop, D. J. (2005): Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice, Proc.Natl.Acad.Sci.U.S.A (Band 102), Nr. 50, Seite 18171-18176. URL: PM:16330757

[43] Iwase, T.; Nagaya, N.; Fujii, T.; Itoh, T.; Murakami, S.; Matsumoto, T.; Kangawa, K. und Kitamura, S. (2005): Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia, Cardiovasc.Res. (Band 66), Nr. 3, Seite 543-551. URL: PM:15914119

[44] Werner, N.; Junk, S.; Laufs, U.; Link, A.; Walenta, K.; Bohm, M. und Nickenig, G. (2003): Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury, Circ.Res. (Band 93), Nr. 2, Seite e17-e24. URL: PM:12829619

[45] Perry, G.; Sayre, L. M.; Atwood, C. S.; Castellani, R. J.; Cash, A. D.; Rottkamp, C. A. und Smith, M. A. (2002): The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications, CNS.Drugs (Band 16), Nr. 5, Seite 339-352. URL: PM:11994023

[46] Jenner, P. (2003): Oxidative stress in Parkinson's disease, Ann.Neurol. (Band 53 Suppl 3), Seite S26-S36. URL: PM:12666096

[47] Friedman, A. und Galazka-Friedman, J. (2001): The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress, Adv.Neurol. (Band 86), Seite 137-142. URL: PM:11553971

[48] Skotland, T.; Sontum, P. C. und Oulie, I. (2002): In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging, J.Pharm.Biomed.Anal. (Band 28), Nr. 2, Seite 323-329. URL: PM:11929675

[49] Foster-Gareau, P.; Heyn, C.; Alejski, A. und Rutt, B. K. (2003): Imaging single mammalian cells with a 1.5 T clinical MRI scanner, Magn Reson.Med. (Band 49), Nr. 5, Seite 968-971. URL: PM:12704781

[50] Okabe, M.; Ikawa, M.; Kominami, K.; Nakanishi, T. und Nishimune, Y. (1997): 'Green mice' as a source of ubiquitous green cells, FEBS Lett. (Band 407), Nr. 3, Seite 313-319. URL: PM:9175875

[51] Fleige, G.; Seeberger, F.; Laux, D.; Kresse, M.; Taupitz, M.; Pilgrimm, H. und Zimmer, C. (2002): In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking, Invest Radiol. (Band 37), Nr. 9, Seite 482-488. URL: PM:12218443

[52] Wong, S. H.; Knight, J. A.; Hopfer, S. M.; Zaharia, O.; Leach, C. N., Jr. und Sunderman, F. W., Jr. (1987): Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct, Clin.Chem. (Band 33), Nr. 2 Pt 1, Seite 214-220. URL: PM:3802504

[53] Frank, J. A.; Miller, B. R.; Arbab, A. S.; Zywicke, H. A.; Jordan, E. K.; Lewis, B. K.; Bryant, L. H., Jr. und Bulte, J. W. (2003): Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents, Radiology (Band 228), Nr. 2, Seite 480-487. URL: PM:12819345

[54] Lewin, M.; Carlesso, N.; Tung, C. H.; Tang, X. W.; Cory, D.; Scadden, D. T. und Weissleder, R. (2000): Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells, Nat Biotechnol. (Band 18), Nr. 4, Seite 410-414. URL: PM:10748521

[55] Kalish, H.; Arbab, A. S.; Miller, B. R.; Lewis, B. K.; Zywicke, H. A.; Bulte, J. W.; Bryant, L. H., Jr. und Frank, J. A. (2003): Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition, Magn Reson.Med. (Band 50), Nr. 2, Seite 275-282. URL: PM:12876703

[56] Shapiro, E. M.; Skrtic, S. und Koretsky, A. P. (2005): Sizing it up: cellular MRI using micron-sized iron oxide particles, Magn Reson.Med. (Band 53), Nr. 2, Seite 329-338. URL: PM:15678543

[57] Arbab, A. S.; Bashaw, L. A.; Miller, B. R.; Jordan, E. K.; Lewis, B. K.; Kalish, H. und Frank, J. A. (2003): Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging, Radiology (Band 229), Nr. 3, Seite 838-846. URL: PM:14657318

[58] Sun, R.; Dittrich, J.; Le-Huu, M.; Mueller, M. M.; Bedke, J.; Kartenbeck, J.; Lehmann, W. D.; Krueger, R.; Bock, M.; Huss, R.; Seliger, C.; Grone, H. J.; Misselwitz, B.; Semmler, W. und Kiessling, F. (2005): Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison, Invest Radiol. (Band 40), Nr. 8, Seite 504-513. URL: PM:16024988

[59] Zimmer, C.; Weissleder, R.; Poss, K.; Bogdanova, A.; Wright, S. C., Jr. und Enochs, W. S. (1995): MR imaging of phagocytosis in experimental gliomas, Radiology (Band 197), Nr. 2, Seite 533-538. URL: PM:7480707

[60] Modo, M.; Mellodew, K.; Cash, D.; Fraser, S. E.; Meade, T. J.; Price, J. und Williams, S. C. (2004): Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study, Neuroimage. (Band 21), Nr. 1, Seite 311-317. URL: PM:14741669

[61] Schroeter, M.; Saleh, A.; Wiedermann, D.; Hoehn, M. und Jander, S. (2004): Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia, Magn Reson.Med. (Band 52), Nr. 2, Seite 403-406. URL: PM:15282824

[62] Katchanov, J.; Waeber, C.; Gertz, K.; Gietz, A.; Winter, B.; Bruck, W.; Dirnagl, U.; Veh, R. W. und Endres, M. (2003): Selective neuronal vulnerability following mild focal brain ischemia in the mouse, Brain Pathol. (Band 13), Nr. 4, Seite 452-464. URL: PM:14655751

[63] Endres, M.; Namura, S.; Shimizu-Sasamata, M.; Waeber, C.; Zhang, L.; Gomez-Isla, T.; Hyman, B. T. und Moskowitz, M. A. (1998): Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family, J.Cereb.Blood Flow Metab (Band 18), Nr. 3, Seite 238-247. URL: PM:9498840

[64] Himmelreich, U.; Weber, R.; Ramos-Cabrer, P.; Wegener, S.; Kandal, K.; Shapiro, E. M.; Koretsky, A. P. und Hoehn, M. (2005): Improved stem cell MR detectability in animal models by modification of the inhalation gas, Mol.Imaging (Band 4), Nr. 2, Seite 104-109. URL: PM:16105508

[65] Prass, K.; Meisel, C.; Hoflich, C.; Braun, J.; Halle, E.; Wolf, T.; Ruscher, K.; Victorov, I. V.; Priller, J.; Dirnagl, U.; Volk, H. D. und Meisel, A. (2003): Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation, J.Exp.Med. (Band 198), Nr. 5, Seite 725-736. URL: PM:12939340